Showing results (1041-1050 of 5,010) with videos related to

Sort By:
Pageof 501
American Journal of Clinical Oncology|November 3, 2015
Total Lifetime and Cancer-related Costs for Elderly Patients Diagnosed With Anal Cancer in the United StatesAshish A Deshmukh, Hui Zhao, Luisa Franzini, et al.
American Journal of Clinical Oncology|November 3, 2015
Clinical Outcomes of Patients With Gastrointestinal Malignancies Participating in Phase I Clinical TrialsAaron Denson, Nancy Burke, Georgine Wapinsky, et al.
American Journal of Clinical Oncology|October 22, 2014
Intratumoral Vascular Shunting: Biomarker of Clinical Outcome and Source of Circulating Tumor Cells?Amy R Deipolyi, Andrew X Zhu, Rahmi Oklu
American Journal of Clinical Oncology|June 1, 1989
Chemotherapy plus RA233 in the treatment of oat cell lung cancerA Lipton, H A Harvey, B Walker, et al.
American Journal of Clinical Oncology|January 26, 2018
Patterns of Care and Outcomes of Hypofractionated Chemoradiation Versus Conventionally Fractionated Chemoradiation for Glioblastoma in the Elderly PopulationWaqar Haque, Vivek Verma, Edward B Butler, et al.
American Journal of Clinical Oncology|October 19, 2017
Patterns of Failure in Patients With Adult Medulloblastoma Presenting Without Extraneural MetastasisMeriem Mokhtech, Christopher G Morris, Daniel J Indelicato, et al.
American Journal of Clinical Oncology|October 1, 1985
Chemotherapy of large bowel carcinoma--fluorouracil (FU) + hydroxyurea (HU) vs. methyl-CCNU, oncovin, fluorouracil, and streptozotocin (MOF-Strep). An Eastern Cooperative Oncology Group studyP F Engstrom, J M MacIntyre, A J Schutt, et al.
American Journal of Clinical Oncology|February 1, 1987
Treatment of liver metastases with a combination of chemotherapy and hyperfractionated external radiation therapyP I Raju, Y Maruyama, P DeSimone, et al.
American Journal of Clinical Oncology|March 7, 2018
Targeting Tumor Metabolism With Statins During Treatment for Advanced-stage Pancreatic CancerNick A Iarrobino, Beant Gill, Mark E Bernard, et al.
American Journal of Clinical Oncology|March 10, 2018
Impact of Health Insurance Status on Prostate Cancer Treatment Modality Selection in the United StatesTrevor J Bledsoe, Henry S Park, Charles E Rutter, et al.
Pageof 501